Inventor · disambiguated record
Andres A. Gutierrez
Also filed as: GUTIERREZ ANDRES · GUTIERREZ ANDRES A · GUTIÉRREZ ANDRÉS
8 granted patents·10 pending applications·89 citations·filing 2006–2025
88Inventor score
Files withBRISTOL MYERS SQUIBB CO10ALIMI HOJABR4EPIVAX INC1NORTHEY ROBERT1OCULUS INNOVATIVE SCIENCES INC1
Top patents by PatentIndex Score
18 records- 0196US11274152B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 15, 2022·6 cites·12 claims
- 0293US10081681B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 25, 2018·17 cites·18 claims
- 0392US8147444B2Methods of treating or preventing peritonitis with oxidative reductive potential water solutionALIMI HOJABR·Filed 2007·Granted Apr 3, 2012·21 cites·43 claims
- 0491US9072726B2Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solutionALIMI HOJABR·Filed 2009·Granted Jul 7, 2015·16 cites·17 claims
- 0590US8323252B2Method of treating skin ulcers using oxidative reductive potential water solutionALIMI HOJABR·Filed 2006·Granted Dec 4, 2012·19 cites·23 claims
- 0686US8834445B2Methods of treating or preventing peritonitis with oxidative reductive potential water solutionALIMI HOJABR·Filed 2012·Granted Sep 16, 2014·7 cites·19 claims
- 0782US9782434B2Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solutionOCULUS INNOVATIVE SCIENCES INC·Filed 2015·Granted Oct 10, 2017·3 cites·13 claims
- 0881US2024150459A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0977US2022185892A1Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat TumorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1074US2025163155A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1171US2025197495A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1269US2021122820A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1364US2020062845A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1459US2018244773A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1558US2018028562A1Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solutionSONOMA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1657US10617715B2Methods of treating or preventing biofilm associated infections with free available chlorine free available chlorine waterNORTHEY ROBERT·Filed 2009·Granted Apr 14, 2020·0 cites·18 claims
- 1753US2023192777A1Epitopic vaccine for african swine fever virusEPIVAX INC·Filed 2020·Application pending·0 cites
- 1850US2016326248A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andres A. Gutierrez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →